• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > About > Annual reports > Annual Report 2022

2022 Asia highlights

It would be best if patients didn’t have to go to hospital and could take their medicine at home. I hope that with ASHAs’ hard work, one day visceral leishmaniasis will be eliminated.​

Shishu Kumari is an Accredited Social Health Activist (ASHA) facilitator in the Saran district of Bihar, India. She has been working as an ASHA for 14 years and has seen how visceral leishmaniasis treatment has evolved. While the earlier treatment lasted for a full month, the current treatment is given in just one day, bringing hope for sustainable elimination of visceral leishmaniasis in South Asia.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Boosting access for sustained elimination of visceral leishmaniasis in India
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Shishu Kumari, an Accredited Social Health Activist (ASHA) facilitator in Bihar, India, is among the more than one million female ASHAs across India working to support maternal care, childhood immunization, nutrition, control of neglected tropical diseases, and other public health priorities.

ASHAs act as a bridge between the healthcare system and the community, providing crucial information about basic health services and encouraging people in rural and remote areas to seek timely medical care. In 2022, ASHAs received the WHO Director-General’s Global Health Leaders Award in recognition of their outstanding contribution to protecting and promoting health.

ASHAs have played an important role in India’s significant strides towards eliminating visceral leishmaniasis (VL) as a public health problem. Reported cases in the country have fallen from 44,533 in 2007 to just 834 in 2022.

Complementing ASHAs’ work at the community level, DNDi is supporting the national elimination programme with our Centres of Excellence (COEs) project, which aims to strengthen the referral system to district hospitals for the management of complicated cases of leishmaniasis and bring diagnosis and treatment closer to patients’ homes.

Together with our COE partners, DNDi teams are working to set up dedicated leishmaniasis wards, upgrade laboratories with essential supplies, establish standard operating procedures for managing complex cases, and develop training modules for ASHAs, nurses, doctors, laboratory technicians, and pathologists. By the end of 2022, the project had trained and retrained around 1,000 ASHAs in the Saran and Purnea districts to identify and refer patients to the COEs.

Asian innovation driving progress for neglected patients

More than 70% of the disease burden of dengue is estimated to be in Asia, where severe dengue has become a leading cause of hospitalization and death among children and adults in many countries. The climate-sensitive disease is the most widely distributed and rapidly spreading mosquito-borne viral disease in the world, but there are no specific drugs to treat it.

Launched in 2022, the Dengue Alliance is a global initiative joining leading medical research institutes from dengue-endemic countries, including in India, Malaysia, and Thailand, to develop affordable and accessible treatments for dengue. Together, we are building on lessons from successful South-South R&D collaborations, including our recent development of ravidasvir for hepatitis C with partners in Malaysia, Thailand, and Egypt. With the broad scientific expertise, public leadership, and commitment represented among Dengue Alliance members, we are confident that our partnership can develop the essential health tools that the prevailing medical innovation system has yet to deliver.

Journalists visit the Siriraj Center of Research Excellence in Dengue and Emerging Pathogens at Siriraj Hospital in Bangkok during the October 2022 DNDi Media Workshop

Science journalism in an age of climate-sensitive diseases

As the COVID-19 pandemic so clearly brought to light, journalists play a crucial role in communicating accurate information about public health. They are often the only barrier against fake news and misinformation that may circulate about health and science.

To support reporters in fulfilling this vital role, DNDi created a media workshop programme for health and science reporters from Africa, Asia, and Latin America. It aims to help reporters better understand neglected diseases, the complex science behind discovering, developing, and delivering new treatments, and the stigma and discrimination that those impacted often face.

In October 2022 in Bangkok, Thailand, we held our first-ever media workshop in Asia, bringing together 15 health and science journalists from Malaysia, Bangladesh, Sri Lanka, India, and Nepal on the side-lines of the 2022 International Congress of Tropical Medicine and Malaria. The three-day, fully funded workshop was designed to give journalists a thorough introduction to neglected climate-sensitive diseases in the region and to hone their understanding of the scientific rationale behind efforts to develop new drugs to treat them, including as critical tools in the climate adaptation agenda. Numerous workshop participants went on to publish articles as a direct result of their attendance at the workshop – a win for all involved.

BACK TO 2022 ANNUAL REPORT

Photo credits: Matt Bouch-DNDi; Luke Duggleby-DNDi

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
This website uses necessary cookies to function. If you give your consent, we will also use statistical, functional, and marketing cookies. See Cookie Policy.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo